B2 receptor — Drug Target

All drugs that target B2 receptor — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Bradykinin receptor antagonist

Phase 2 pipeline (1)

• Deucrictibant high dose · Pharvaris Netherlands B.V. · Bradykinin receptor antagonist · Cardiovascular
  Deucrictibant is a bradykinin receptor 2 antagonist.